These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16018576)

  • 1. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum.
    Kabuto H; Nishizawa M; Tada M; Higashio C; Shishibori T; Kohno M
    Neurochem Res; 2005 Mar; 30(3):325-32. PubMed ID: 16018576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT
    Neurochem Res; 2011 Dec; 36(12):2244-9. PubMed ID: 21769642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.
    Kabuto H; Tada M; Kohno M
    Biol Pharm Bull; 2007 Mar; 30(3):423-7. PubMed ID: 17329831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity.
    Kabuto H; Yokoi I; Iwata-Ichikawa E; Ogawa N
    Neurochem Res; 1999 Dec; 24(12):1543-8. PubMed ID: 10591404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT; Janjua N; Takayama F; Mankura M
    J Oleo Sci; 2013; 62(1):21-8. PubMed ID: 23357814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum.
    Opacka-Juffry J; Wilson AW; Blunt SB
    Brain Res; 1998 Nov; 810(1-2):27-33. PubMed ID: 9813228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.
    Kabuto H; Amakawa M; Mankura M; Yamanushi TT; Mori A
    Neurochem Res; 2009 Jul; 34(7):1299-303. PubMed ID: 19219632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.
    Iida M; Miyazaki I; Tanaka K; Kabuto H; Iwata-Ichikawa E; Ogawa N
    Brain Res; 1999 Aug; 838(1-2):51-9. PubMed ID: 10446316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.
    Tanaka K; Yoshioka M; Miyazaki I; Fujita N; Ogawa N
    Neurosci Lett; 2002 Mar; 321(1-2):45-8. PubMed ID: 11872253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain.
    Ueda Y; Komatsu M; Hiramatsu M
    Neurochem Res; 1996 Aug; 21(8):909-14. PubMed ID: 8895844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals.
    Yoshioka M; Tanaka Ki; Miyazaki I; Fujita N; Higashi Y; Asanuma M; Ogawa N
    Neurosci Res; 2002 Jul; 43(3):259-67. PubMed ID: 12103444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain.
    Asanuma M; Ogawa N; Nishibayashi S; Kawai M; Kondo Y; Iwata E
    Arch Int Pharmacodyn Ther; 1995; 329(2):221-30. PubMed ID: 8540762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
    Ogawa N; Tanaka K; Asanuma M; Kawai M; Masumizu T; Kohno M; Mori A
    Brain Res; 1994 Sep; 657(1-2):207-13. PubMed ID: 7820619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
    Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
    Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain.
    Matsuura K; Kabuto H; Makino H; Ogawa N
    Brain Res; 1996 Sep; 733(1):101-4. PubMed ID: 8891252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
    Petersén A; Hansson O; Puschban Z; Sapp E; Romero N; Castilho RF; Sulzer D; Rice M; DiFiglia M; Przedborski S; Brundin P
    Eur J Neurosci; 2001 Nov; 14(9):1425-35. PubMed ID: 11722604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Brain Res Bull; 2001 Jan; 54(1):77-82. PubMed ID: 11226716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zingerone as an antioxidant against peroxynitrite.
    Shin SG; Kim JY; Chung HY; Jeong JC
    J Agric Food Chem; 2005 Sep; 53(19):7617-22. PubMed ID: 16159194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.
    Kunikowska G; Jenner P
    Brain Res; 2001 Dec; 922(1):51-64. PubMed ID: 11730701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.